WallStreetZenWallStreetZen

NASDAQ: NXL
Nexalin Technology Inc Stock

Open Broker Account
$2.37+0.02 (+0.85%)
Updated Dec 5, 2022
NXL Price
$2.37
Fair Value Price
$3.89
Market Cap
$17.25M
52 Week Low
$1.04
52 Week High
$3.23
P/E
N/A
P/B
2.72x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
N/A
Earnings
N/A
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.31
Operating Cash Flow
N/A
Beta
0.96
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

NXL Overview

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. It also engages in the development of Generation 2, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiates, chronic pain, Alzheimer's disease, and dementia. The company was incorporated in 2021 and is headquartered in Houston, Texas.

Zen Score

Industry Average (32)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how NXL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

NXL ($2.37) is undervalued by 39.02% relative to our estimate of its Fair Value price of $3.89 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
NXL ($2.37) is significantly undervalued by 39.02% relative to our estimate of its Fair Value price of $3.89 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
NXL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
There are 30 more NXL due diligence checks available for Premium users.

Be the first to know about important NXL news, forecast changes, insider trades & much more!

NXL News

Valuation

NXL fair value

Fair Value of NXL stock based on Discounted Cash Flow (DCF)
Price
$2.37
Fair Value
$3.89
Undervalued by
39.02%
NXL ($2.37) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
NXL ($2.37) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation

NXL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.72x
Industry
3.76x
NXL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

NXL's financial health

Profit margin

Revenue
$545.3k
Net Income
-$135.4k
Profit Margin
-24.8%

Assets to liabilities

Assets
$8.4M
Liabilities
$2.0M
Debt to equity
0.31
NXL's short-term assets ($8.34M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
NXL's short-term assets ($8.34M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
NXL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$943.7k
Investing
$0.0
Financing
$8.5M

NXL vs Medical Device Stocks

TickerMarket Cap1d %P/EP/B
NXL$17.25M+0.85%N/A2.72x
IVC$17.10M-5.63%-0.21x0.21x
VERO$18.86M+4.49%-0.48x2.17x
TNON$19.55M-5.95%N/A1.51x
STRR$14.68M-3.96%-0.70x0.37x

Nexalin Technology Stock FAQ

What is Nexalin Technology's quote symbol?

NASDAQ: NXL) Nexalin Technology trades on the NASDAQ under the ticker symbol NXL. Nexalin Technology stock quotes can also be displayed as NASDAQ: NXL.

If you're new to stock investing, here's how to buy Nexalin Technology stock.

What is the 52 week high and low for Nexalin Technology (NASDAQ: NXL)?

(NASDAQ: NXL) Nexalin Technology's 52-week high was $3.23, and its 52-week low was $1.04. It is currently -26.63% from its 52-week high and 127.88% from its 52-week low.

How much is Nexalin Technology's stock price per share?

(NASDAQ: NXL) Nexalin Technology stock price per share is $2.37 today (as of Dec 5, 2022).

What is Nexalin Technology's Market Cap?

(NASDAQ: NXL) Nexalin Technology's market cap is $17.25M, as of Dec 6, 2022.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Nexalin Technology's market cap is calculated by multiplying NXL's current stock price of $2.37 by NXL's total outstanding shares of 7,279,961.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.